• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年-早老性痴呆:一种有效的心理治疗-抗凝方案的随访数据。

Senile-presenile dementia: follow-up data on an effective psychotherapy-anticoagulant regimen.

作者信息

Walsh A C, Walsh B H, Melaney C

出版信息

J Am Geriatr Soc. 1978 Oct;26(10):467-70. doi: 10.1111/j.1532-5415.1978.tb03326.x.

DOI:10.1111/j.1532-5415.1978.tb03326.x
PMID:701697
Abstract

This report contains follow-up data on the effects of an anticoagulant-psychotherapy regimen in presenile and senile dementia. Over a two-year period, 49 such patients who were seriously ill were treated with a Coumadin-psychotherapy regimen; 34 (69 percent) improved (4 of them dramatically) and 15 (31 percent) did not improve or became worse. The underlying pathologic processes are discussed, with the rationale for therapy.

摘要

本报告包含关于抗凝-心理治疗方案对早老性和老年性痴呆影响的随访数据。在两年时间里,49例重症此类患者接受了华法林-心理治疗方案;34例(69%)病情改善(其中4例显著改善),15例(31%)病情未改善或恶化。文中讨论了潜在的病理过程以及治疗的基本原理。

相似文献

1
Senile-presenile dementia: follow-up data on an effective psychotherapy-anticoagulant regimen.老年-早老性痴呆:一种有效的心理治疗-抗凝方案的随访数据。
J Am Geriatr Soc. 1978 Oct;26(10):467-70. doi: 10.1111/j.1532-5415.1978.tb03326.x.
2
Senile and presenile dementia: further observations on the benefits of a dicumarol-psychotherapy regimen.老年和老年前期痴呆:双香豆素-心理治疗方案益处的进一步观察
J Am Geriatr Soc. 1972 Mar;20(3):127-31. doi: 10.1111/j.1532-5415.1972.tb00781.x.
3
The psycho-chemical treatment of dementia: a very cost-effective therapy program.
Med Hypotheses. 1991 Jan;34(1):66-8. doi: 10.1016/0306-9877(91)90068-a.
4
Presenile dementia: further experience with an anticoagulant-psychotherapy regimen.早老性痴呆:抗凝-心理治疗方案的更多经验
J Am Geriatr Soc. 1974 Oct;22(10):467-72. doi: 10.1111/j.1532-5415.1974.tb04816.x.
5
Huntington's disease: improvement with an anticoagulant-psychotherapy regimen.
J Am Geriatr Soc. 1978 Mar;26(3):127-9. doi: 10.1111/j.1532-5415.1978.tb01222.x.
6
[Trends in modern international gerontological research. Psychiatric aspects].
Aktuelle Gerontol. 1978 Jan;8(1):57-64.
7
Behavioral change in the chronicity pattern of dementia in the institutional geriatric resident.
J Am Geriatr Soc. 1976 Nov;24(11):522-8. doi: 10.1111/j.1532-5415.1976.tb03276.x.
8
Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.与因其他适应症接受长期华法林治疗的患者相比,接受长期华法林抗凝治疗的房颤患者患各类痴呆症的几率更高。
J Am Heart Assoc. 2016 Jul 11;5(7):e003932. doi: 10.1161/JAHA.116.003932.
9
Anticoagulant therapy for aggressive dementia patients.
Am J Psychiatry. 1989 Feb;146(2):278-9. doi: 10.1176/ajp.146.2.278c.
10
Anticoagulant therapy for senile dementia.老年痴呆症的抗凝治疗。
J Am Geriatr Soc. 1972 Nov;20(11):556-9. doi: 10.1111/j.1532-5415.1972.tb00758.x.

引用本文的文献

1
Fibrinogen-tau Aggregates Exacerbate Tau Pathology and Memory Deficits in Alzheimer's Disease Model Mice.纤维蛋白原- tau聚集体加剧阿尔茨海默病模型小鼠的tau病理变化和记忆缺陷。
Neurosci Bull. 2025 Feb 19. doi: 10.1007/s12264-025-01366-8.
2
Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.直接口服抗凝剂(DOACs)用于靶向治疗凝血酶,凝血酶是阿尔茨海默病脑血管和神经元功能障碍的关键介质。
Biomedicines. 2022 Aug 4;10(8):1890. doi: 10.3390/biomedicines10081890.
3
Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.
阿尔茨海默病:使用凝血酶抑制剂达比加群酯治疗的合理性。
Int J Mol Sci. 2021 Apr 30;22(9):4805. doi: 10.3390/ijms22094805.
4
Anticoagulants for Treatment of Alzheimer's Disease.抗凝血剂治疗老年痴呆症。
J Alzheimers Dis. 2020;77(4):1373-1382. doi: 10.3233/JAD-200610.
5
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model.长期达比加群治疗可延缓 TgCRND8 小鼠模型阿尔茨海默病的发病机制。
J Am Coll Cardiol. 2019 Oct 15;74(15):1910-1923. doi: 10.1016/j.jacc.2019.07.081.
6
The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.阿尔茨海默病肽β-淀粉样蛋白通过激活凝血因子XII促进凝血酶生成。
J Thromb Haemost. 2016 May;14(5):995-1007. doi: 10.1111/jth.13209. Epub 2016 Feb 29.
7
A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.一种新型的 Aβ-纤维蛋白原相互作用抑制剂可挽救阿尔茨海默病小鼠的血栓形成和认知功能下降。
J Exp Med. 2014 Jun 2;211(6):1049-62. doi: 10.1084/jem.20131751. Epub 2014 May 12.
8
Fibrinogen and altered hemostasis in Alzheimer's disease.纤维蛋白原与阿尔茨海默病的血液凝固改变。
J Alzheimers Dis. 2012;32(3):599-608. doi: 10.3233/JAD-2012-120820.
9
Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.纤维蛋白原和β-淀粉样蛋白的关联改变了血栓形成和纤维蛋白溶解:阿尔茨海默病的一个可能致病因素。
Neuron. 2010 Jun 10;66(5):695-709. doi: 10.1016/j.neuron.2010.05.014.